Nia Therapeutics, Inc.

Amendment

CIK: 0001758725·Other Health Care·DELAWARE·Filed: Jun 3, 2026

Total Offering

$26,499,997

Amount Sold

$23,573,844

Investors

37

First Sale

Dec 22, 2021

Offering Details

Type: Equity
Exemptions: Rule 506(b)
Entity Type: Corporation
Non-Accredited Investors: No

Related Persons

Name	Role
Daniel Rizzuto
Daniel Utin
Larry Greenberg
Jonathan Wachter
Milton Morris
Michael Kahana

Company

Nia Therapeutics, Inc.

119 BRAINTREE ST. UNIT 703

ALLSTON, MA, 02134

2675607402

SEC Filing

0001758725-26-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.